This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Chronic pancreatitis is a long-term condition where the pancreas becomes inflamed and scarred. It affects the pancreas’ ability to produce digestive enzymes and hormones, leading to a wide range of digestive symptoms, such as abdominal pain, nausea, vomiting, and weight loss. It is caused by long-term alcohol or tobacco abuse and can also be triggered by genetic factors, infections, and certain medications. The exact cause of chronic pancreatitis is not known, however, certain risk factors can increase the likelihood of developing the disease. These include a history of heavy alcohol consumption, genetic predisposition, gallstones, cystic fibrosis, and certain medications. The most common symptoms of chronic pancreatitis are abdominal pain, nausea, and vomiting. Other symptoms can include weight loss, oily stools, and jaundice. Diagnosis is usually made through a combination of medical imaging tests, such as CT scans, MRI scans, and endoscopic ultrasound. Treatment of chronic pancreatitis typically involves lifestyle changes, such as abstaining from alcohol, quitting smoking, and following a healthy diet. Medications may be prescribed to reduce inflammation and pain, and surgery may be required for severe cases. Chronic pancreatitis can be a debilitating condition, and long-term management is essential. Regular checkups with a healthcare provider and lifestyle changes can help to reduce the risk of complications and improve overall quality of life.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States